Black Share Price

Black Share Price

NASDAQ: BDTX | Micro Cap | Healthcare
$1.43
-$0.01 (-0.69%) Last updated on 19 Nov, 2026 | 01:26 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Black Stock Performance

Open
$1.43
Prev. Close
$1.44
Circuit Range
N/A
Day Range
$1.39 - $1.45
Year Range
$1.39 - $4.04
Volume
16,943
Average Traded
$1.42

Black Share Price Today

As of 19 November 2026, Black Diamond Therapeutics, Inc.'s share price is $1.43. The stock opened at $1.43, compared to its previous close of $1.44. During today's trading session, Black Diamond Therapeutics, Inc.'s share price traded between $1.39 and $1.45, with an average price of $1.42. Over the past 52 weeks, the stock has recorded a high of $4.04 and a low of $1.39. In terms of performance, Black Diamond Therapeutics, Inc.'s share price has declined by 36.16% over the last six months and is down 62.57% on a year-on-year basis.

Black Share Price Chart

Line chart of the Black price trend over the selected period. The price fell overall, ranging from 1.39 to 1.45, ending at 1.43.
$1.39$1.45
L
Show Current Price
H

Black Stock Fundamentals & Key Indicators

Market Cap
$81.32M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.77
Revenue (TTM)
$70.00B
Return On Equity (TTM)
-50.03%
Profit Margin
31.96%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
33.80%

Black Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$15.12-$9.04-$9.91-$10.01
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A40.21%-9.62%-1.01%

Black Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$70.00
Net Profit-$91.17-$82.44-$69.68$22.37
Net Profit MarginN/AN/AN/A31.96%
Income ChangeN/A9.58%15.48%132.10%

Black Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets10.5721.4624.5328.55
Current Assets132.44101.18134.03127.71
Total Assets143.01122.64158.57156.26
Non Current Liabilities15.0718.7822.1925.3
Current Liabilities15.7320.5719.6515.26
Total Liabilities30.839.3641.8340.56
Shareholders' Equity112.2183.29116.74115.7

Black Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating29.61-62.3-66.72-85.08
Investing-44.9116.9716.3553.37
Financing-0.1525.5571.930.18

About Black

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The foundation of companies has been built upon a deep understanding of cancer genetics, onco-protein structure and function, and medicinal chemistry. Its clinical-stage program, silevertinib (formerly BDTX-1535), a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor, is currently being studied in a Phase 2 clinical trial in patients with epidermal growth factor receptor mutant (EGFRm) non-small cell lung cancer (NSCLC). The Company manages its operations as a single operating segment and single reportable segment.

Black Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.84
$1.43
-19.44%
Oct 2026
$1.87
$1.77
-5.59%
Sep 2026
$2.09
$1.88
-17.18%
Aug 2026
$1.68
$2.27
+34.72%
Jul 2026
$1.85
$1.69
-8.67%
Jun 2026
$2.21
$1.84
-17.63%
May 2026
$2.63
$2.24
-15.79%
Apr 2026
$2.24
$2.66
+24.88%
Mar 2026
$2.34
$2.13
-13.59%
Feb 2026
$2.47
$2.46
-0.60%
Jan 2026
$2.46
$2.48
+1.64%
Dec 2025
$3.76
$2.44
-36.13%

Black Share Price FAQs